{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:52:56Z","timestamp":1785297176648,"version":"3.55.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"RADxUP","award":["R01 DA049644-02S2"],"award-info":[{"award-number":["R01 DA049644-02S2"]}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI036214"],"award-info":[{"award-number":["P30 AI036214"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA049644"],"award-info":[{"award-number":["R01DA049644"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI036214"],"award-info":[{"award-number":["P30 AI036214"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People who inject drugs may be at elevated SARS-CoV-2 risk due to their living conditions and\/or exposures when seeking or using drugs. No study to date has reported upon risk factors for SARS-CoV-2 infection among people who inject drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>Between October, 2020 and June, 2021, participants aged \u226518 years from San Diego, California, USA and Tijuana, Baja California, Mexico who injected drugs within the last month underwent interviews and testing for SARS-CoV-2 RNA and antibodies. Binomial regressions identified correlates of SARS-CoV-2 seropositivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 386 participants, SARS-CoV-2 seroprevalence was 36.3% (95% CI: 31.5%-41.1%); 92.1% had detectable IgM antibodies. Only 37.5% had previously been tested. Seroprevalence did not differ by country of residence. None tested RNA-positive. Most (89.5%) reported engaging in \u22651 protective behavior [e.g., facemasks (73.5%), social distancing (46.5%), or increasing handwashing\/sanitizers (22.8%)]. In a multivariate model controlling for sex, older age, and Hispanic\/Latinx\/Mexican ethnicity were independently associated with SARS-CoV-2 seropositivity, as was engaging in sex work (AdjRR: 1.63; 95% CI: 1.18\u20132.27) and having been incarcerated in the past six months (AdjRR: 1.49; 95% CI: 0.97\u20132.27). Comorbidities and substance using behaviors were not associated with SARS-CoV-2 seropositivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this community-based study of people who inject drugs in the San Diego-Tijuana border region, over one third were SARS-CoV-2 seropositive, exceeding estimates from the general population in either city. We found no evidence that substance use behaviors were associated with an elevated risk of SARS-CoV-2 infection, but observed that circumstances in the risk environment, notably sex work and incarceration, were independently associated with higher SARS-CoV-2 seroprevalence. Our findings suggest that a binational policy response to COVID-19 mitigation is warranted beyond the closure of the U.S.-Mexico border. Furthermore, decriminalizing sex work and drug use could reduce the burden of COVID-19 among people who inject drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0260286","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T13:26:08Z","timestamp":1637587568000},"page":"e0260286","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7724-691X","authenticated-orcid":true,"given":"Steffanie A.","family":"Strathdee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Abramovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Harvey-Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudelia","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Artamonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Chaillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ignacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1064-7097","authenticated-orcid":true,"given":"Alheli","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"issue":"24","key":"pone.0260286.ref001","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2020.8598","article-title":"COVID-19 and Racial\/Ethnic Disparities","volume":"323","author":"M Webb Hooper","year":"2020","journal-title":"JAMA."},{"issue":"10","key":"pone.0260286.ref002","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/infdis\/jiaa474","article-title":"COVID-19 Pandemic: Disparate Health Impact on the Hispanic\/Latinx Population in the United States","volume":"222","author":"R Macias Gil","year":"2020","journal-title":"J Infect Dis"},{"issue":"6","key":"pone.0260286.ref003","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1377\/hlthaff.2021.00098","article-title":"Racial\/Ethnic Disparities In COVID-19 Exposure Risk, Testing, And Cases At The Subcounty Level In California.","volume":"40","author":"MB Reitsma","year":"2021","journal-title":"Health Aff (Millwood)"},{"issue":"12","key":"pone.0260286.ref004","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1176\/appi.ps.202000215","article-title":"Clinical Risk Factors for COVID-19 Among People With Substance Use Disorders","volume":"71","author":"H Wen","year":"2020","journal-title":"Psychiatr Serv."},{"key":"pone.0260286.ref005","article-title":"Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021","author":"L Wang","year":"2021","journal-title":"World Psychiatry."},{"issue":"1","key":"pone.0260286.ref006","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/M20-1212","article-title":"Collision of the COVID-19 and Addiction Epidemics","volume":"173","author":"ND Volkow","year":"2020","journal-title":"Ann Intern Med"},{"key":"pone.0260286.ref007","doi-asserted-by":"crossref","first-page":"108584","DOI":"10.1016\/j.drugalcdep.2021.108584","article-title":"The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland","volume":"221","author":"BL Genberg","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"pone.0260286.ref008","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41380-020-00880-7","article-title":"COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States","volume":"26","author":"QQ Wang","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"11","key":"pone.0260286.ref009","doi-asserted-by":"crossref","first-page":"e29319","DOI":"10.2196\/29319","article-title":"Associations of Substance Use With Behavioral Adherence to Centers for Disease Control and Prevention Guidelines for COVID-19 Mitigation: Survey Study","volume":"7","author":"MA Monnig","year":"2021","journal-title":"JMIR Public Health Surveill"},{"key":"pone.0260286.ref010","doi-asserted-by":"crossref","first-page":"646206","DOI":"10.3389\/fpsyt.2021.646206","article-title":"A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic","volume":"12","author":"A Farhoudian","year":"2021","journal-title":"Front Psychiatry"},{"key":"pone.0260286.ref011","doi-asserted-by":"crossref","first-page":"103127","DOI":"10.1016\/j.drugpo.2021.103127","article-title":"A rapid review of the impacts of \"Big Events \" on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19","volume":"92","author":"C Zolopa","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"1","key":"pone.0260286.ref012","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12954-021-00499-z","article-title":"Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic","volume":"18","author":"K Lindqvist","year":"2021","journal-title":"Harm Reduct J."},{"key":"pone.0260286.ref013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.puhe.2021.01.004","article-title":"Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services","volume":"192","author":"S Croxford","year":"2021","journal-title":"Public Health"},{"issue":"1","key":"pone.0260286.ref014","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7326\/M20-3799","article-title":"Characteristics of COVID-19 in Homeless Shelters: A Community-Based Surveillance Study","volume":"174","author":"JH Rogers","year":"2021","journal-title":"Ann Intern Med"},{"key":"pone.0260286.ref015","article-title":"COVID-19 Prevalence among People Experiencing Homelessness and Homelessness Service Staff during Early Community Transmission in Atlanta, Georgia, April-May 2020","author":"JC Yoon","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"17","key":"pone.0260286.ref016","doi-asserted-by":"crossref","first-page":"521","DOI":"10.15585\/mmwr.mm6917e1","article-title":"Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters\u2014Four U.S. Cities, March 27-April 15, 2020","volume":"69","author":"E Mosites","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"pone.0260286.ref017","unstructured":"Consulado General de M\u00e9xico en San Diego. Presentation of the results of the \"Survey on Prevalence of Covid-19 in Baja California\" 2021 [Available from: https:\/\/consulmex.sre.gob.mx\/sandiego\/index.php\/comunicados-2020\/782-survey-on-prevalence-of-covid-19-in-baja-california."},{"key":"pone.0260286.ref018","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-7517-11-4","article-title":"Evaluating the impact of Mexico\u2019s drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda","volume":"11","author":"AM Robertson","year":"2014","journal-title":"Harm Reduct J"},{"issue":"1","key":"pone.0260286.ref019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ije\/dyaa163","article-title":"Cohort Profile: The Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO).","volume":"50","author":"PM Gorbach","year":"2021","journal-title":"Int J Epidemiol"},{"key":"pone.0260286.ref020","unstructured":"U.S. Department of Agriculture (USDA)\u2014Economic Research Service. Food Security in the U.S.\u2014Measurement 2020 [Available from: https:\/\/www.ers.usda.gov\/topics\/food-nutrition-assistance\/food-security-in-the-us\/measurement\/#measurement."},{"key":"pone.0260286.ref021","unstructured":"Food and Drug Administration (FDA). Maverick\u2122 SARS-CoV-2 Multi-Antigen Serology Panel v2 01030ART-01 [Available from: https:\/\/www.fda.gov\/media\/142915\/download."},{"issue":"4","key":"pone.0260286.ref022","doi-asserted-by":"crossref","first-page":"e0249938","DOI":"10.1371\/journal.pone.0249938","article-title":"Target specific serologic analysis of COVID-19 convalescent plasma2021","volume":"16","author":"S Ikegami","journal-title":"PLoS One."},{"key":"pone.0260286.ref023","article-title":"SARS-CoV-2 antibody prevalence among homeless people, sex workers and shelter workers in Denmark: a nationwide cross-sectional study.","author":"AR R\u00f6thlin Eriksen","year":"2021","journal-title":"medRxiv"},{"issue":"6","key":"pone.0260286.ref024","doi-asserted-by":"crossref","first-page":"e2113787","DOI":"10.1001\/jamanetworkopen.2021.13787","article-title":"Health and Economic Outcomes Associated With COVID-19 in Women at High Risk of HIV Infection in Rural Kenya","volume":"4","author":"NM Kavanagh","year":"2021","journal-title":"JAMA Network Open"},{"key":"pone.0260286.ref025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2147\/IJWH.S303565","article-title":"Commercial Sex Work During Novel Coronavirus (SARS-CoV-2) Era in the Niger Delta Region: Relationships Between Knowledge, Preventive Practice, and Transmission Potential","volume":"13","author":"G Avwioro","year":"2021","journal-title":"Int J Womens Health."},{"issue":"10243","key":"pone.0260286.ref026","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(20)31033-3","article-title":"Sex workers must not be forgotten in the COVID-19 response","volume":"396","author":"L Platt","year":"2020","journal-title":"Lancet"},{"issue":"Suppl 4","key":"pone.0260286.ref027","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/00333549101250S414","article-title":"A comparison of registered and unregistered female sex workers in Tijuana, Mexico","volume":"125","author":"N Sirotin","year":"2010","journal-title":"Public Health Rep"},{"issue":"4","key":"pone.0260286.ref028","doi-asserted-by":"crossref","first-page":"e19048","DOI":"10.1371\/journal.pone.0019048","article-title":"Social and structural factors associated with HIV infection among female sex workers who inject drugs in the Mexico-US border region.","volume":"6","author":"SA Strathdee","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"pone.0260286.ref029","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1007\/s11606-021-07022-x","article-title":"Covid-19 in the California State Prison System: An Observational Study of Decarceration, Ongoing Risks, and Risk Factors","volume":"36","author":"ET Chin","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"5","key":"pone.0260286.ref030","doi-asserted-by":"crossref","first-page":"556","DOI":"10.15288\/jsad.2020.81.556","article-title":"Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply","volume":"81","author":"M Bonn","year":"2020","journal-title":"J Stud Alcohol Drugs"},{"key":"pone.0260286.ref031","unstructured":"San Diego Epidemiology and Research for COVID Health (SEARCH). SARS-CoV-2 Genomics 2021 [Available from: https:\/\/searchcovid.info\/genomics\/."},{"issue":"8","key":"pone.0260286.ref032","doi-asserted-by":"crossref","first-page":"ofaa325","DOI":"10.1093\/ofid\/ofaa325","article-title":"No Evidence of SARS-CoV-2 Seminal Shedding Despite SARS-CoV-2 Persistence in the Upper Respiratory Tract","volume":"7","author":"SA Rawlings","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"pone.0260286.ref033","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMc2025179","article-title":"Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19","volume":"383","author":"FJ Ibarrondo","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"pone.0260286.ref034","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"QX Long","year":"2020","journal-title":"Nat Med"},{"issue":"7","key":"pone.0260286.ref035","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jiph.2021.05.003","article-title":"Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic\/presymptomatic COVID-19 patients","volume":"14","author":"Y Chen","year":"2021","journal-title":"J Infect Public Health"},{"key":"pone.0260286.ref036","unstructured":"County of San Diego. COVID-19 Vaccinations Report\u2014San Diego County Residents with COVID19 Vaccinations by Age Group 2021 [Available from: https:\/\/www.sandiegocounty.gov\/content\/dam\/sdc\/hhsa\/programs\/phs\/Epidemiology\/COVID-19%20Vaccinations%20by%20Age%20Group.pdf."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T13:26:44Z","timestamp":1637587604000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0260286"}},"subtitle":[],"editor":[{"given":"Kimberly","family":"Page","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0260286","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.05.21261671","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}